Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
09.07.24
/
50%
€44.60
Target price
09.07.25
€49.94
Performance (%)
4.04%
Price
09:30
€46.40
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 4.04%. This prediction currently runs until 09.07.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | -3.361% | -3.361% |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at JPMorgan Chase & Co. from $47.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€27.40
20.11.23
20.11.23
€32.04
20.11.24
20.11.24
67.15%
09:30
09:30